Girentuximab (Anti-CA9 / Carbonic anhydrase 9)
Girentuximab (Anti-CA9 / Carbonic anhydrase 9) (A2578-GRP)
Products
Description
Girentuximab (Anti-CA9 / Carbonic anhydrase 9) is a chimeric monoclonal antibody that targets and binds to Carbonic Anhydrase IX (CAIX) / Carbonic Anhydrase 9 (CA9), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC). MW:145.5 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2578 |
| Target | Carbonic Anhydrase |